Authors: Rivat C et al.
Anesthesiology 144(4):761–763, April 2026
Summary:
This editorial highlights a novel and underappreciated mechanism in neuropathic pain: primary afferent inhibition originating from dorsal root ganglion (DRG) neurons. Traditionally, pain transmission has been viewed as predominantly excitatory, with peripheral neurons simply relaying nociceptive signals to the spinal cord. However, this study challenges that paradigm by demonstrating that a subset of primary sensory neurons actively suppresses pain signaling.
Using advanced experimental techniques, the underlying study identified a small population of DRG neurons capable of releasing GABA, an inhibitory neurotransmitter. These neurons exert dual effects within the spinal cord: directly inhibiting excitatory interneurons involved in pain transmission and indirectly enhancing inhibitory circuits through a feed-forward mechanism. This dual signaling allows a single sensory neuron to modulate pain processing at multiple levels before signals reach higher centers.
In neuropathic pain states, particularly following nerve injury, this inhibitory system becomes impaired. The study shows that direct inhibitory signaling weakens, leading to a state of disinhibition where normally nonpainful stimuli—such as light touch—are perceived as painful (mechanical allodynia). Importantly, restoring activity in these inhibitory neurons reduced hypersensitivity in animal models, normalizing responses to tactile stimuli.
These findings shift the understanding of chronic pain from being purely a problem of excessive excitation to one of failed inhibition at the earliest stages of sensory processing. The work also reinforces the growing importance of peripheral targets, such as the DRG, in developing new pain therapies.
While the results are based on animal models and require validation in humans, they open the door to new therapeutic strategies focused on enhancing inhibitory signaling rather than simply suppressing excitatory pathways.
Key Points:
- A subset of primary sensory neurons can actively inhibit pain transmission
- These neurons use GABA and glutamate to modulate spinal pain circuits
- Neuropathic pain involves loss of inhibitory control (disinhibition), not just increased excitation
- Restoring inhibitory signaling reduces mechanical hypersensitivity in models
- The dorsal root ganglion represents a promising target for future pain therapies
What You Should Know:
We’ve been focused on shutting down pain signals—but this suggests the real problem may be that the body’s natural “brakes” are failing. Future treatments may work better by restoring inhibition rather than just blocking transmission. That’s a major shift in how we think about chronic pain.
We would like to thank Anesthesiology for allowing us to summarize and share this article.